Britain approves Allergan’s Botox drug for migraine

Published July 10, 2010

Britain approves Allergan’s Botox drug for migraine
LONDON (Reuters) – Britain has become the first country to approve Allergan Inc’s anti-wrinkle injection Botox as a treatment for migraine, opening up a new market for the product.
Read more on Reuters

Norm Stamper: The Politics of Cannabis and Color
Alice Huffman’s explanation of the California NAACP’s endorsement of Proposition 19, the state initiative calling for the regulated legalization and taxation of marijuana, was well…
Read more on The Huffington Post